0.1476
Wellgistics Health Inc stock is traded at $0.1476, with a volume of 32.37M.
It is up +2.43% in the last 24 hours and down -9.67% over the past month.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
See More
Previous Close:
$0.1441
Open:
$0.1171
24h Volume:
32.37M
Relative Volume:
3.07
Market Cap:
$18.78M
Revenue:
$23.34M
Net Income/Loss:
$-101.27M
P/E Ratio:
-0.1143
EPS:
-1.2919
Net Cash Flow:
$-11.74M
1W Performance:
+17.14%
1M Performance:
-9.67%
6M Performance:
-74.59%
1Y Performance:
-96.25%
Wellgistics Health Inc Stock (WGRX) Company Profile
Name
Wellgistics Health Inc
Sector
Industry
Phone
1-843-302-1785
Address
3000 BAYPORT DRIVE SUITE 950, TAMPA
Compare WGRX vs HITI, PETS, POM, HKPD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WGRX
Wellgistics Health Inc
|
0.1476 | 18.34M | 23.34M | -101.27M | -11.74M | -1.2919 |
|
HITI
High Tide Inc
|
2.47 | 205.68M | 452.61M | -35.30M | 13.25M | -0.3863 |
|
PETS
Petmed Express Inc
|
2.35 | 50.29M | 182.67M | -64.87M | -22.92M | -3.1193 |
|
POM
Pomdoctor Ltd Adr
|
0.376 | 40.87M | 0 | 0 | 0 | 0.00 |
|
HKPD
Cellyan Biotechnology Co Ltd
|
0.6949 | 14.92M | 0 | 0 | 0 | 0.00 |
Wellgistics Health Inc Stock (WGRX) Latest News
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives - National Today
Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX - The Joplin Globe
Wellgistics forms joint venture with KareRx Hub for pharma distribution By Investing.com - Investing.com Australia
Wellgistics Health (WGRX) Forms Strategic Joint Venture with Kar - GuruFocus
Wellgistics forms joint venture with KareRx Hub for pharma distribution - Investing.com
New Wellgistics-KareRx venture aims to speed prescriptions for 200,000+ - Stock Titan
Wellgistics Health files to sell 3.57M shares of common stock for holders - MSN
Rosen Law Firm Investigating Potential Securities Claims Against Wellgistics Health - National Today
Exit Recap: Is Wellgistics Health Inc stock good for income investors2026 Valuation Update & Consistent Growth Stock Picks - baoquankhu1.vn
Penny stock Wellgistics Health ends Silverback deal, cuts dilution risk - MSN
Why Clearsign Technologies Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Sahm
Wellgistics Health Inc. (WGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Wellgistics Health Ends Settlement, Shifts Financing Strategy - The Globe and Mail
Wellgistics Health (WGRX) director Herman Gary L files initial Form 3 - Stock Titan
Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk - Benzinga
Bond Watch: Is Wellgistics Health Inc undervalued by DCF analysisWall Street Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Ideas: What is Wellgistics Health Incs P E ratio telling usPortfolio Update Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
Wellgistics Health, Inc. (WGRX) Terminates Settlement Agreement – SEC Form 8-K Filing April 3, 2026 - Minichart
Wellgistics Health (WGRX) director Eric Michael Sherb files initial Form 3 - Stock Titan
Wellgistics Health Incterminates settlement agreement with Silverback Capital on April 3, 2026SEC filing - marketscreener.com
Wellgistics Health ends share settlement agreement with Silverback Capital By Investing.com - Investing.com South Africa
Wellgistics Health ends share settlement agreement with Silverback Capital - Investing.com
Wellgistics Health Terminates Section 3(a)(10) Settlement With Silverback, Halting Further Share Issuance - TradingView — Track All Markets
Wellgistics (NASDAQ: WGRX) halts 3(a)(10) share settlement plan - Stock Titan
Wellgistics Health Raises Capital via Private Note Financing - The Globe and Mail
Wellgistics Health, Inc. Enters Note Purchase Agreement: SEC Filing Details, Nasdaq Listing, and Company Information - Minichart
Wellgistics Health Launches Up to $1.25 Million Note Offering With 20% OID - TradingView — Track All Markets
Wellgistics Health (WGRX) raises $1.25M via 0% notes with covenants - Stock Titan
WGRX Stock Price, Quote & Chart | WELLGISTICS HEALTH INC (NASDAQ:WGRX) - ChartMill
Wellgistics Health (WGRX) approves board-authorized 1:25–1:200 reverse split - Stock Titan
Wellgistics Health, Inc. (WGRX) Explores $105M Acquisition of Neuritek to Expand Healthcare Platform - Insider Monkey
Wellgistics Health (WGRX) director Marlene Velez files Form 3 - Stock Titan
12 Penny Stocks with Insider Buying in 2026 - Insider Monkey
Exclusive:Top Public Companies Holding XRP - Bitget
Wellgistics Health, Inc. announced that it expects to receive $1.25 million in funding - marketscreener.com
Sentiment Recap: How does Wellgistics Health Inc score in quality rankings2026 Trading Volume Trends & Technical Entry and Exit Tips - baoquankhu1.vn
Pullback Watch: Can Wellgistics Health Inc continue delivering strong returns2026 Bull vs Bear & Daily Growth Stock Tips - baoquankhu1.vn
[PRER14C] Wellgistics Health, Inc. Preliminary Revised Information Statement - Stock Titan
Thunder Rock Capital Serves as Exclusive M&A Advisor to Neuritek Therapeutics, Inc. on $105,000,000 Proposed Acquisition by Wellgistics Health, Inc. - ChartMill
Earnings Update: Does Wellgistics Health Inc align with a passive investing strategy2026 Setups & Accurate Technical Buy Alerts - baoquankhu1.vn
Why Are Shares Of Wellgistics Health Falling? - Sahm
Wellgistics Health (NASDAQ: WGRX) OKs flexible 1-for-25–200 reverse split - Stock Titan
WGRX Wellgistics Health (NASDAQ) earnings pre-market: $0.13 price, LOI in focus - Meyka
Wellgistics signs letter of intent to acquire Neuritek By Investing.com - Investing.com Australia
Wellgistics Health Inc. Evaluates $105M Acquisition of Neuritek Therapeutics - nationaltoday.com
Wellgistics Health shares are trading lower a... - Benzinga
Wellgistics signs letter of intent to acquire Neuritek - Investing.com
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders - ACCESS Newswire
A pharmacy platform is weighing a $105M stock deal for a brain-drug developer - Stock Titan
Wellgistics Health 2025 10-K: $23.3M Revenue, $(1.43) EPS - TradingView
Wellgistics Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Wellgistics Health Inc Stock (WGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):